Procurement of Cardiovascular System Medications 3 - AQ2025/1627

This tender, identified by reference AQ2025/1627, concerns the procurement of medications specifically for the cardiovascular system, designated as 'Cardiovascular System Medications 3'. The objective is to acquire a supply of pharmaceutical products essential for treating conditions related to the heart and blood vessels. The scope includes the purchase of various drugs falling under this therapeutic category, likely for use in healthcare facilities, hospitals, or public health programs. Bidders are expected to be licensed pharmaceutical suppliers capable of providing high-quality, certified medications. The tender documentation will specify the exact list of required medications, their dosages, quantities, packaging requirements, and delivery timelines. Emphasis will be placed on compliance with pharmaceutical regulations, product quality, and competitive pricing. The goal is to ensure the availability of critical cardiovascular medications to meet patient needs.

This is a supplies contract in the health and medical services and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 236.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.